Cathie Wood's position in Adaptive Biotechnologies is currently worth $52.3M. That's 0.38% of their equity portfolio (44th largest holding). The investor owns 2.61% of the outstanding Adaptive Biotechnologies stock. The first Adaptive Biotechnologies trade was made in Q2 2020. Since then Cathie Wood bought shares fifteen more times and sold shares on five occasions. The investor's estimated purchase price is $93.1M, resulting in a loss of 44%.
Cathie Wood bought shares of Shopify, Intellia, and Adaptive Biotechnologies on Tuesday. Shopify has surrendered 26% of its value over the past two weeks sin...